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INTRODUCTION 
 
Microorganisms play a fundamental role in the etiology of pulp and 
periapical diseases. Their control and elimination are important during 
endodontic treatment24. Unlike primary endodontic infections, which are 
polymicrobial in nature and dominated by gram-negative anaerobic rods, the 
microorganisms involved in secondary infections are composed of one or a 
few bacterial species15,64. 
Enterococcus faecalis is more likely to be found in failed cases than in 
primary infection66. It is commonly found in a high percentage of root canal 
failures and it is able to survive in the root canal as a single organism or as a 
major component of the flora9. Studies investigating its occurrence in root-
filled teeth with periradicular lesions have demonstrated a prevalence 
ranging from 24 to 77%41,42,47. Starvation increases the resistance of E. 
faecalis 1000-fold to 10,000-fold50. It is probable that the physiologic state 
of the cells, particularly in retreatment cases, is closest to the starvation 
phase69. 
Cleaning and shaping of the root canal reduce the bacterial population 
but do not completely eliminate them. One possible reason for persistent 
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endodontic infection might be due to the retention of microorganisms in the dentinal 
tubules of the root canal54 as a result of the anatomic complexity and diversity of root 
canals, as well as the subsequent limitations in access by instruments and 
irrigants46,27,57. Hence, the use of an intra canal medicament helps in the elimination of 
bacteria that remain even after cleaning and shaping, thereby providing an 
environment conducive for periapical tissue repair6. 
Calcium hydroxide is the most widely used intra canal medicament, requiring 
a disinfection period of 7 days66. The high pH of calcium hydroxide formulations 
alters the biologic properties of bacterial lipopolysaccharides in the cell walls of gram-
negative species and inactivates membrane transport mechanisms, resulting in 
bacterial cell toxicity63. However, several studies demonstrated that Ca(OH)2 fails to 
eradicate Enterococcus faecalis residing in infected root canal systems14. 
An explanation for the resistance against Ca(OH)2 might be the ability of E. 
faecalis to invade dentinal tubules, isthmuses and other ramifications of a root canal 
system. Furthermore, it has been documented to be able to survive for prolonged 
periods in high alkalinity and harsh nutrient conditions14. Evans et al. (2002) reported 
that the survival of E. faecalis at high pH was due to the functioning of a proton pump 
with the capacity to acidify cytoplasm. On the other hand, the buffering capacity of 
dentin can inhibit the pH increase and the antimicrobial activity of Ca(OH)2 in the 
root canal41. The search for a better alternative has lead to the introduction of newer 
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antimicrobial agents like chlorhexidine, metronidazole, and particulate bioactive glass 
as intracanal medicament. 
In vitro studies have indicated that chlorhexidine may be potent in the 
elimination of E. faecelis from the root canal system14. It is active against a wide range 
of microorganisms, such as Gram positive and Gram-negative bacteria12. CHX has an 
antibacterial efficacy comparable to that of sodium hypochlorite (NaOCl)39. In 
addition, it is also effective against strains resistant to Ca(OH)2. 2% CHX has been 
proved to be an efficient agent against E. faecalis21. 
In addition to its immediate action on bacteria, chlorhexidine can be adsorbed 
onto and subsequently released from dental tissues, resulting in substantive 
antimicrobial activity or “substantivity”2,23. Such substantivity has been shown in vitro 
in root canal medicated with chlorhexidine by using different vehicles ( i.e liquid, gel 
or controlled release devices CRD). 
The rationale for using sustained release systems for intracanal medication is 
that it is necessary to sterilize the root canal system and to maintain its sterility 
throughout the treatment. It follows, therefore, that the medication should remain 
active at a constant concentration for a designated time period. In addition, if the 
antibacterial medicament has an affinity for dentine and will be slowly released from 
it, this in turn will prolong the period of antimicrobial activity.  
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Hydrogels are gaining increasing popularity in the area of controlled-release 
drug delivery43. These polymers are generally glassy in the dehydrated state but swell 
to become an elastic gel upon water penetration. The entrapped drug within the 
swelling matrix concomitantly dissolves and diffuses through the swollen network 
into surrounding aqueous environment.  The rate of drug release from hydrogels is 
regulated by crosslinking density and the extent of swelling43. 
Poly (vinyl alcohol) (PVA) is a hydrophilic polymer with properties of 
forming hydrogel. It absorbs water, swells forms and it has extensively been used in 
controlled-release applications44. It has been used as a controlled drug delivery system 
for rectal propranolol, atenalol, indomethacin, phenylpropanolamine and 
emedastin/HCI36. 
Previous studies have shown that polyvinyl alcohol has good compatibility 
with chlorhexidine digluconate and has been used as drug carrier in stomatological 
dressings35,48. However, none of the studies have utilized polyvinyl alcohol as a drug 
carrier for intracanal medicament. 
In this study we have analyzed the release kinetics of 2 % CHX from 
PVA hydrogel and studied the efficacy of this sustained release mechanism 
against  E faecalis in vitro. 
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AIMS AND OBJECTIVES 
 
a. To synthesize Polyvinyl alcohol + 2 % Chlorhexidine matrix and 
Polyvinyl alcohol + Silver nanoparticles + 2 % Chlorhexidine matrix. 
b. Analysis of the sustained release of 2% chlorhexidine from Poly vinyl 
alcohol hydrogel. 
c. In vitro Evaluation of the efficacy of this sustained release mechanism 
against E faecalis by measurement and comparison of the zone of 
inhibition over a period of a week. 
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REVIEW OF LITERATURE 
 
Enterococcus faecalis & Intra canal Medicaments: 
The literature is teeming with immense studies on the use of various 
medicaments for the disinfection of the root canal and their efficacy against 
E. Faecalis.  
Haapasalo et al. 14 (1987) tested Camphorated paramonochlorophenol 
(CMC) and a calcium hydroxide compound, Calasept, for their disinfecting 
efficacy toward E. faecallis – infected dentin. Liquid CMCP rapidly and 
completely disinfected tubules, whereas CMCP in gaseous form disinfected 
tubules less rapidly. Calasept failed to eliminate, even superficial E. faecalis 
in the tubules.  
Chong et al.6 (1992) stated that intra canal medicaments should only 
be used for root canal disinfection as part of controlled asepsis in infected 
root canals, and their role is secondary to cleaning and shaping of the root 
canal. Thorough canal debridement and adequate canal preparation are more 
pertinent and their importance is emphasized. Bacteriological sampling may 
be necessary if a tooth does not respond to treatment, to help in the choice of 
intra canal medicament.  
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Gomes et al.13 (1996) studied variation in the susceptibilities of 
endodontic microflora to chemical procedures and confirmed that organisms 
like E. faecalis were recovered from canals after thorough Bio Mechanical 
Preparations. He concluded certain organisms like E. faecalis are difficult to 
be eliminated from infected root canals. 
Sundqvist et al.69 (1998) conducted a study to determine what 
microbial flora was present in teeth after failed root canal therapy and to 
establish the outcome of conservative re-treatment. They concluded that the 
microbial flora in canals after failed endodontic therapy differed markedly 
from the flora in untreated teeth. Infection at the time of root filling and size 
of the periapical lesion were factors that had a negative influence on the 
prognosis. Three of four endodontic failures were successfully managed by 
re-treatment. 
Bettina Basrani et al.2 (2002) conducted a spectrophotometric 
analysis using (1) 2% chlorhexidine (CHX) gel, (2) 0.2% CHX gel, (3) 2% 
CHX solution, (4) Ca(OH)2, (5) Ca(OH)2+ 0.2% CHX gel, (6) 2% CHX 
solution + a 25% CHX-containing controlled-release device, (7) saline and 
(8) gel vehicle. After medication for 7 days , the authors concluded that 
canal dressing for 1 week with 2% CHX gel may provide residual 
antimicrobial activity against E. faecalis. 
8 
 
Isabelle Portenier et al.19 (2003) Stated that in endodontics, E. 
faecalis is rarely present in primary apical periodontitis, but it is the 
dominant microorganism in rootfilled teeth presenting with post-treatment 
apical periodontitis. It is often isolated from the root canal in pure culture, 
but it can also be found togetherwith some other bacteria or yeasts. While 
there is no doubt about the pathogenicity of E. faecalis in endodontic 
infections, it seems to be rarely associated with acute infections and flare-
ups. Eradication of E. faecalis from the root canal remains a challenge, while 
chlorhexidine and combinations of disinfectants show some promise. 
Vivacqua-Gomes et al.71 (2005) showed that neither single- nor 
multiple-visit root canal treatment ex vivo, eliminated E. faecalis completely 
from dentinal tubules. Up to 60 days after root filling, E. faecalis remained 
viable inside dentinal tubules. When no sealer was used, E. faecalis 
presented a higher growth rate. 
Kayaoglu et al.25 (2005) concluded that a minor increase in pH up to 
8.5, which may be a consequence of insufficient treatment with alkaline 
medicaments such as calcium hydroxide, increases the collagen-binding 
ability of E. faecalis, in vitro. This can be a critical mechanism by which E. 
faecalis predominates in persistent endodontic infections. 
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Sustained release of Chlorhexidine  
Friedman M et al.10 (1985) studied the effectiveness of a sustained-
release delivery system in the form of orthodontic appliances coated by ethyl 
cellulose polymer for chlorhexidine release in plaque prevention. They 
concluded that the conditions in the oral cavity and the formulation used did 
not facilitate such prolonged prevention of plaque accumulation. However, it 
may be assumed that by altering the film components and method of 
preparation (i.e., initial drug concentration and film thickness applied), it 
will be possible in clinical use, too, to sustain the necessary level of 
chlorhexidine release for longer periods. Such a delivery system could be a 
treatment of choice for partial-denture- and orthodontic-appliance-wearers.  
D.B. Mirth et al.7 (1989)  prepared Copolymers of hydroxyethyl 
methacrylate (HEMA) and methyl methacrylate (MMA) to fabricate a 
membrane- controlled reservoir-type controlled-release delivery system for 
chlorhexidine for intra-oral use. The chlorhexidine released on day 30 was 
biologically active, as determined by a serial dilution assay against 
Streptococcus mutans.  
L Heling et al.32 (1992) evaluated the effect of chlorhexidine in 
solution and in a sustained-release device as an intra canal medication. The 
intra canal medicaments tested were 0.2%chlorhexidine gluconate solution 
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(CHX), chlorhexidine in a sustained-release device (1.2 mg) (SRD), 
camphoratedparamonochlorophenol (CMCP), and a control (no 
medication).Each medicament was introduced into the lumen of infected 
dentine specimen and Incubated for 5 min. 24 h, 48 h or 7 days at 37°C. The 
bacteriological samples were taken and were collected in test-tubes 
containing growth medium and incubated for 24 h. The optical density of the 
medium was recorded by means of a spectrophotometer at a wavelength of 
540 nm. There was a statistically significant difference between the control 
group and all the medicaments tested. 
L Heling et al.,31 (1992)  evaluated the efficacy of the antibacterial 
activity of Ca(OH)2 and a sustained-release device containing chlorhexidine 
(SRD) in both sterlization and prevention of secondary infection of the root 
canal system. The degree of bacterial  infection of the root canal was tested 
after incubation periods of 24 h, 72 h and 7 days with the medicaments. 
Their efficacy in preventing secondary infection after recontamination was 
tested after 72 h and 7 days. The results demonstrated that both formulations 
of the SRD significantly reduced the bacterial population in the primary 
infected groups, as well as preventing secondary infection of the dentinal 
tubules in the recontaminated group. By contrast, Ca(OH)2 did not show any 
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antibacterial activity, and failed to sterilize the dentinal tubules or prevent 
secondary infection after recontamination at the time periods examined.  
Senel S et al. 56 (2000)  designed a formulation containing Gels (at 1 or 2% 
concentration) or film forms of chitosan containing 0.1 or 0.2% CHX and 
their in vitro release properties were studied. The antifungal activity of 
chitosan itself as well as the various formulations containing CHX was also 
examined. Release of CHX from gels was maintained for 3 h. A prolonged 
release was observed with film formulations. The highest antifungal activity 
was obtained with 2% chitosan gel containing 0.1% CHX. 
Peter N. Galgut 45 (2001) made a reference for the slow release 
preparation of Chlorhexidine for professional application into periodontal 
pockets containing 2.5 mg of chlorhexidine digluconate in a hydrolysed 
gelatin base. When placed in periodontqal pockets, the gelatin base degrades 
and releases the chlorhexidine over a 7 to 10 days period. The sustained 
release of the antimicrobial over a prolonged period of time provided an 
enhanced disinfection of the pockets in which it is placed. 
Shaul Lin Ofer Zuckerman60 (2003) used 5% chlorhexidine and 
slow-release device (Activ Point) for 7 days and placed it inside 9 infected 
root canals, in another nine canals irrigation with 10 ml of 0.2% 
chlorhexidine was used, and the remaining nine served as positive control. 
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Powder dentin samples obtained from within the canal lumina were 
examined for the presence of vital bacteria. Heavy bacterial infection was 
observed at the layer close to the lumen in the control specimens, decreasing 
rapidly from layer to layer up to the deepest layer tested (400-500 µm), 
which contained several hundred colony forming units. Viable bacteria in 
each layer of dentin were significantly reduced with chlorhexidine irrigation 
solution and were completely eliminated with the chlorhexidine slow-release 
device. 
Palmer G et al40 (2004) investigated the use of an experimental GIC 
as a carrier for the release of chlorhexidine acetate (CHX) at included 
concentrations ranging from 0.5% to 13.0% of CHX by weight. Release into 
water was examined using high-performance liquid chromatography. All 
measurable chlorhexidine was released within 22 h1/2, however this was 
less than 10% of the total mass incorporated in the specimens. An increased 
percentage of CHX incorporated into the powder gave an increased release 
into the surrounding water. The bulk of the CHX was retained within the 
cement. In order to explore the effect of CHX -inclusion on the cement 
properties, compressive strengths, working and setting times were also 
measured. In general, compressive strengths were found to be decreased in 
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direct proportion to the quantity of CHX added, while working and setting 
times increased. 
Cetin EO et al.5 (2004) prepared Cellulose acetate films containing 
chlorhexidine gluconate, indomethacin, and meloxicam and cut in a form to 
fit to the periodontal pocket anatomy. The release of active agents was 
studied in 10 ml artificial saliva at 37 degrees C. Determinations were 
carried out spectrophotometrically and the formulations showed two 
different release patterns for a total observation period of approximately 120 
hrs. When the formulations of the three active agents were compared, the 
release patterns of meloxicam and chlorhexidine gluconate were found to be 
similar, while the indomethacin-containing formulation exhibited the fastest 
release rate. 
Spangberg67 (2005) evaluated the suitability of using chitosan, poly 
(lactide glycolide acid) (PLGA), and polymethyl methacrylate (PMMA) to 
control the release of chlorhexidine digluconate (CHX) from a prototype of 
controlled release drug device for root canal disinfection.  The result showed 
that release rate of CHX was the greatest in the noncoated group, followed 
by the chitosan-coated group, the PLGA-coated group, and the PMMA-
coated group. Pores were observed on the surface of the prototypes that were 
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coated with PLGA and PMMA. When the pore size was smaller, the release 
rate was lower.  
K.J. Anusavice et al 23 (2006) tested the hypothesis that the release of 
chlorhexidine from a urethane dimethacrylate and triethylene glycol 
dimethacrylate resin system can be effectively controlled by the 
chlorhexidine diacetate content and pH. The filler concentrations were 9.1, 
23.1, or 33.3 wt%, and the filled resins were exposed to pH 4 and pH 6 
acetate buffers. The results showed that Fickian diffusion was the dominant 
release mechanism. The rates of release were significantly higher in pH 4 
buffer, which was attributed to the increase of chlorhexidine diacetate 
solubility at lower pH. The higher level of filler loading reduced the degree 
of polymerization, leading to a greater loss of organic components and 
higher chlorhexidine release rates. 
Yoon Lee, DDS et al.73 (2008) tested the following intracanal 
medicaments in infected root canals:  calcium hydroxide, a polymeric 
chlorhexidine-controlled release device (PCRD), a polymeric controlled 
release device without chlorhexidine (CHX), 0.2% CHX solution, and sterile 
saline. Dentin samples (at 200 µm and 400 µm depths) were collected from 
the medicated canal lumens after 1 week of medication and placed in growth 
medium. Bacterial growth was assessed spectrophotometrically. The OD 
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values at both depths were significantly lower in the PCRD group than in the 
other experimental groups. These results indicate that a PCRD can be an 
effective intracanal medicament against E. faecalis.  
Pragati S et al.51 (2009) showed that fibers containing 20% (v/v) 
chlorhexidine, when placed into periodontal pockets, exhibited a prompt and 
marked reduction in signs and symptoms of periodontal disease.   To retard 
drug release, drug-impregnated monolithic fibers were developed by adding 
drug to molten polymers, spinning at high temperature and subsequent 
cooling. Several polymers such as poly (e-caprolactone) (PCL), 
polyurethane, polypropylene, cellulose acetate propionate and ethyl vinyl 
acetate (EVA) have been investigated as matrices for the delivery of drug to 
the periodontal pocket. Sustained release devices composed of cross-linked 
fish gelatin (bycoprotein) containing chlorhexidine diacetate or 
chlorhexidine hydrochloride have been developed by Steinberg. Films based 
on synthetic biodegradable polymers such as poly (lactide-co-glycolide) 
(PLGA) containing tetracycline have been developed for modulated-release 
of drug in the periodontal pocket as slab like device.  
Raso, Eliete et al.53 (2010) prepared and characterized a controlled 
release system based on porous silica loaded with chlorhexidine (CHX) to 
evaluate its antimicrobial activity. The kinetics release parameter of the drug 
16 
 
showed that the CHX systems release profile followed zero order release 
until 400 h after the burst effect at the first 8 hrs. Chlorhexidine therapeutic 
range was reached near first hour for all systems. The chlorhexidine porous 
silica system was biologically active against Enterococcus faecalis and 
Candida albicans in vitro. The systems showed an efficient CHX controlled 
release modulated by the presence of the β-cyclodextrin and by the porous 
silica matrices, providing effective antimicrobial activity. 
Simchuer Wilaiwan et al 62 (2010) prepared silk fibroin (SF)/gelatin 
(G) hybrid films by a solvent evaporation method for loading chlorhexidine 
diacetate (CHX). The SF and G solution in different ratios were mixed with 
CHX and placed on the 5 cm polystyrene plates before drying to obtain 
hybrid films. It was found that the CHX released from the SF film in higher 
rate than hybrid and G films. Polarity, flexibility as well as component ratio 
of each polymer play important role on the releasing of CHX.  
Racheli Ben-Knaz52 (2010) demonstrated the entrapment of 
chlorhexidine digluconate (CHD) within an aggregated silver matrix, a metal 
known for its own biocidal qualities, forming the CHD withsilver composite. 
The bactericidal efficacy against E. coli is evaluated and compared with the 
separate components. While the bactericidal efficacy of the individual 
ingredients (CHD and metallic silver) is very low, CHD with silver exhibits 
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a markedly enhanced efficacy. This enhanced bactericidal effect is partially 
attributed to the simultaneous release and presence of the active biocidal 
ingredients CHD and AgR in the solution. 
Poly Vinyl Alcohol as sustained releasing agent 
Gay, M. H et al34 (1987) evaluated wound dressings based on 
polyvinyl alcohol, polyhydroxyethyl methacrylate, polyacrylamide and 
polyethylene oxide. He found that release rates are dependent upon water 
content, degree of hydrogel cross linking, concentration of plasticizer, 
polymer molecular weight, degree of hydrolysis of polyvinyl alcohol, and 
solubility of the antimicrobial agent. Polyvinyl alcohol based hydrogels 
containing either tetracycline free base or chlorhexidine diphosphanilate 
were efficacious in-vivo in a wound model with an established 
Streptococcus pyogenes infection. In addition chlorhexidine diphosphanilate 
hydrogels were efficacious against established Staphylococcus aureus 
infections and mixed infections containing both organisms. 
Bruno Gander3 (1989) evaluated three types of polyvinyl alcohol 
which were cross linked by glutaraldehyde to form water swellable materials 
possessing a three dimensional molecular network. Proxyphylline and 
theophylline were incorporated into the polymer networks during the cross 
linking reaction. Drug release from the highly cross linked gels could be 
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controlled over more than 12 hr, as the diffusion process in these very dense 
macromolecular networks is rather slow. The extent of branching and 
entanglement of the polymer chains appeared to have an important effect. In 
addition, the release was influenced greatly by the amount and, to a lesser 
extent, by the type of drug in the network. 
Kazuhiro Morimoto et al.26 (1990) evaluated a bunitrolol preparation 
using poly(vinyl alchol) (PVA) hydrogel for hypertension as a transdermal 
delivery system. The release of bunitrolol from PVA hydrogel followed with 
Fickian diffusion. Longer freezing times, higher polymerization and higher 
concentration of PVA resulted in lower permeationand release. The plasma 
concentration of bunitrolol after application of hydrogel preparation onto the 
abdominal skins was relatively high at early times and sustained a plateau 
level during 48 hrs in rates.  
Pluta J et al.49 (2001)evaluated Dressings made from polyvinyl 
alcohol (PAV) and Hydroxypropylmethylcellulose (HPMC) with the 
addition of glycerol (GLY). The research on the release speed which is 
applied in topical therapy of chlorhexidine digluconate antiseptic in 
biopharmaceutical model proved the existence of close to rectilinear relation 
between the amount of released substance and release time for selected 
formulations. 
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Pluta J et al. 48 (2002). They revealed that depending on the degree of 
polyalcohol hydrolysis, the dressings made on the basis of PVA and 
methylcellulose (MC) with the addition of hydrophilic substances were 
characterized by distinct rheological properties and released the active 
substance in various ways. The studies on the kinetics of the release of 
Chlorhexidine Digluconate, in biopharmaceutical model provided evidence 
of close to rectilinear relationship between the amount of released substance 
and the time of release for selected formulations. 
Jaleh Varshosaz et al.20 (2002) investigated  the effect of drug release 
(theophylline) from Cross-linked poly {vinyl alcohol) (PVA)  polymeric 
network . Changes in glutaraldehyde percentage (or cross-linking density) 
affected the swelling of the films. However, increasing PVA percentage 
caused more swelling. Drug loading efficiency was higher in gels with 
higher glutaraldehyde, PVA and theophylline percentages. Increasing 
contents of PVA and theophylline promoted the diffusion coefficient and 
drug release rate but glutaraldehyde had a reverse effect. The pH did not 
affect the swelling and diffusion coefficient. Water transport and drug 
release mechanism predominantly followed a Fickian model. It may be 
concluded that by changing the PVA structural parameters, a rate-controlled 
drug release is obtained. 
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Pragati et al51 (2009) studied the distinguishable films composed of 
poly vinyl alcohol (PVA) and carboxymethyl-chitosan (CMCS) prepared by 
blending/ casting methods, and loaded with ornidazole as a periodontal drug 
delivery system. The blended films were found to be biocompatible, showed 
pH-responsive swelling, had a good retention at the application site and 
maintained high drug concentration at least for five days. 
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MATERIALS AND ARMAMENTARIUM 
 
MATERIALS: 
 Poly (vinyl alcohol) (PVA) (Fluka) 
 Silver nitrate (AgNO3) (Ranbaxy Lab. Ltd. India ) 
 Sodium Borohydride (NaBH4) (Aldrich Chemicals ) 
 20 % aqueous solution of Chlorhexidine Digluconate( Sigma Aldrich) 
 Distilled water 
 Phosphate buffered saline solution(pH 7.4) 
 Enterococci faecalis (ATCC 29212) 
 Sheep blood agar media (Highmedia) 
 Peptone (Highmedia) 
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ARMAMENTARIUM: 
 100 mL flask 
 Teflon coated magnetic stir bars 
 Sonicator (Cole-Palmer) 
 Electronic Weighing machine(Scaltec) 
 UV spectrometer (Techcomp – 8500, UV-Vis) 
 Vaccum dryer 
 Microcentrifuge tubes 
 Thermostat  
 Hot air oven 
 Incubator 37 oC 
 Petri dishes 
 Test tubes 
 Laminar Flow 
 Micropipette 
 Scale  
 Sterile gloves 
 Mask 
 Sterile Cotton Swab 
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METHODOLOGY FOR DRUG RELEASE: 
Poly (vinyl alcohol) and Chlorhexidine Matrix Preparation: 
Polyvinyl alcohol is a hydrophilic polymer and hence soluble in water. 
Ten gms of  72000 Daltons Molecular weight Poly vinyl alcohol with a 
degree of hydrolysis of 97.5 - 99.5 % was mixed in 100 mL of hot water at 
80-90oC to prepare 10 % solution of Polyvinyl alcohol20. After cooling the 
solution to room temperature, 10 mL of this solution was mixed with 10 mL 
of 2% Chlorhexidine digluconate solution. Chlorhexidine digluconate was 
purchased as 20% aqueous solution which was further diluted to 2% in the 
following manner.  
 
20% Chlorhexidine   =  20 gms in 100 ml of distilled water 
    = 2000 mgs in 100 ml of distilled water 
    = 20 mg in 1ml of distilled water 
The required conc. of 2% Chlorhexidine is to be prepared from a solution of 20 mgs in 1 ml. 
2% Chlorhexidine   = 2 gms in 100 ml of distilled water 
    = 200 mgs in 100 ml of distilled water 
    = 2 mg / ml of distilled water 
Therefore to convert a 20 mg/ml chlorhexidine solution to a 2 mg/ml solution, we diluted 1 ml of the 
concentrated 20 % solution with distilled water to get a 10 ml solution of 2 % Chlorhexidine solution. 
9 ml of distilled water + 1ml of 20 % Chlorhexidine 
    = 10 ml of 2 % Chlorhexidine
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Hence, 1 ml of 20 % aqueous solution of Chlorhexidine digluconate 
was measured using a micropippete  and taken in a test tube, to this 10 ml of 
distilled water was mixed  to make it 2% Chlorhexidine digluconate solution. 
The mixture of 2 % Chlorhexidine digluconate and 10 % Polyvinyl 
alcohol which were taken in equal proportions (10 mL each), were sonicated 
thoroughly and poured into petri dishes. The petri dishes were sealed to 
prevent evaporation and stored in refrigerating conditions of 4 oC28. After 12 
hrs, the hydrogel of Polyvinyl alcohol with the entrapped drug (2 % 
Chlorhexidine digluconate) was obtained. The cause of hydrogel formation 
by PVA is the cross linking between the polymer chains due to ionic 
interaction and hydrogen bonding 20 and imbibation of liquid into them.  
Finally, the gel was air-dried at room temperature for 24 hrs followed 
by a vacuum-drying cycle at 50oC for another 24 h until reaching a constant 
weight. When the water is removed from these swollen biomaterials they are 
called xerogels, which are the dried hydrogels20.  
This xerogel can be stored for a longer term. During the drying 
process of hydrogels, water evaporates from the gel and the surface tension 
of the water causes collapse of polymer chains and thus shrinking of the 
hydrogel body to only small fraction of its swollen size. Water absorption 
into this xerogel occurs by diffusion which is a very slow process leading to 
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very slow swelling. This slow swelling is used to slowly release loaded drug 
molecules. The weight of the xerogel was approximately 1.2 gm. 
PVA + 2 % CHX Matrix Preparation 
 
 
10 ml of 10 % PVA + 10 ml of 2 % CHX were mixed 
and sonicated 
Mixture transferred to Petri dish and refrigerated at 4° 
C for 12 hours 
Formation of Hydrogel 
Hydrogel is air dried at room temperature for 24 hours and 
vacuum dried at 50° c for 24 hours 
This leads to the formation of Xerogel which is weighed to be 
1.2 gms 
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Synthesis of Polyvinyl alcohol stabilized Silver nanoparticles (AgNPs): 
The Polymer (PVA) stabilized Silver nanoparticles are prepared using 
Sodium borohydride (NaBH4) reduction in wet chemical method. The silver 
nitrate (AgNO3) is the precursor and the stabilizer is polyvinyl alcohol.  
A 100 mL flask is used for the synthesis of the nanoparticles. A stock 
solution of 1.35 mM AgNO3 is prepared and sonicated to complete 
dissolution 30. To the 15 mL of this solution, 10 mL of 10 % PVA solution is 
added and stirred for 30 min. The temperature of the solution is raised to 
800C using a thermostat and 1 mL of 0.1M NaBH4 solution (maintained 
under cold condition, 50C because hydrogen is volatile at higher temperature) 
is added dropwise with continuous stirring for 45 min. The colour of the 
solution changes to yellow indicating the presence of AgNPs. A UV 
spectrum of the solution after the nanoparticle formation was taken.  
Presence of the surface plasmon resonance peak at 412 nm confirms the 
formation of pure AgNPs. Now equal quantity (10 mL) of PVA stabilized 
silver nanoparticles and 2% Chlorhexidine digluconate were sonicated and 
casted in a similar manner as described above for PVA and Chlorhexidine 
digluconate until it reached a constant weight of 0.7 gm. 
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PVA +Ag NPs + 2 % CHXP matrix preparation 
 
 
10 ml of 10 % PVA + 15 ml of 1.35mM AgNo3 is 
mixed and stirred for 30 min 
Mixture transferred to a flask  and temperature raised to 
80° C and 1ml of 0.01M NaBH4 at 5° C is added drop wise 
and stirred for 45 seconds 
Colour changes to yellow indicating 
presence of AgNPs 
UV analysis - AgNPs shows peak at 412nm 
10 ml of this solution is taken and mixed with 10 ml of 2 % 
CHX and sonicated 
The Xerogel was  weighed to be 
approximately 0.7 gms 
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Plasmon resonance peak at 412 nm confirms the formation of pure AgNPs 
Analysis of Drug release kinetics: 
The release of chlorhexidine from polyvinyl alcohol is analysed with a 
simple experimental set up. The logic behind such an experimental set up is 
that release of drug from a hydrogel follows simple diffusion from a higher 
concentration to a lower concentration. In this experiment diffusion of the 
drug through a semi-permeable membrane (cellulose acetate membrane) was 
performed. 
The semi-permeable membrane was soaked in phosphate buffered 
saline (PBS) which had pH of 7.4. Phosphate buffered saline is a water-
based salt solution containing sodium chloride, sodium phosphate, and 
potassium chloride and potassium phosphate. It is available in powdered 
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form which can be mixed with appropriate amount of water to make a solution. The 
buffer helps to maintain a constant pH. The osmolarity and ion concentrations of the 
solution usually match those of the human body (isotonic). 
 
The cellulose acetate membrane was clamped carefully to one end of the 
hollow glass tube. 1.2 gm of the test gel i.e PVA + CHX (equivalent to 0.2 gm of 
the drug) was weighed and obtained from the casting prepared and spread 
uniformly on the internal aspect of the membrane. The glass tube was submerged in 
a beaker containing 50 mL of PBS maintained at 37 ± 0.5°C. The PBS solution was 
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stirred continuously by externally driven Teflon coated magnetic bar. At 
predetermined time intervals (30 mins, 1 hour, 1 ½ hours….initially and after 10 
hours the interval was increased to 24 hours), 1 mL samples of the solutions were 
withdrawn and replaced with an equal quantity PBS solution.  UV Spectrum of the 
samples was taken. Presence of absorption peak at 254 nm showed the presence of 
Chlorhexidine in the solution. The drug concentration in the eliquates was thus 
determined using the UV spectrophotometer. The experiment was done for a period 
of a week. 
Analysis of Drug Release 
 
 
A semi permeable membrane was clamped to a hollow 
glass tube and immersed in 50 ml of phosphate buffered 
saline solution 
At predetermined intervals, 1 ml of samples of the 
solution was withdrawn and observed UV 
spectroscopically to determine the concentration 
The experiment was carried out for a 
week and the results tabulated 
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The experiment was repeated for PVA + AgNPs + Chlorhexidine.  Here the 
amount of gel formed was approximately 0.7 gm. Therefore the whole of the test 
gel which contains 0.2 gm of Chlorhexidine by dry weight was used for the 
experiment. Loading of chlorhexidine in both the cases is taken as 0.2 gm to 
standardize the experiment. 
METHODOLOGY FOR MICROBIOLOGICAL STUDIES: 
E. faecalis (ATCC 29212) maintained in stock culture in the Department of 
Microbiology, Madras Medical College was used in this study. Twenty four hours 
growth of E. faecalis grown on sheep blood agar and Mac Conkey agar plates were  
suspended in 1ml of peptone broth and incubated for 4 hours at 37°C. The culture 
suspension was adjusted to match the turbidity equivalent to 0.5 McFarland 
Standard. This was used as the standardized inoculum for all the procedures.  
These inoculate were used to make the lawnculture of the organism using 
sterile cotton swabs on sheep blood agar. The streaked petridishes were incubated at 
37 °C for 24 hrs. When the growth of the organism was confirmed, wells 5 mm 
deep and 10 mm wide in diameter were then punched in the agar plates with a 
sterile punch under laminar flow. A total of 20 wells, (1 plate = 2 wells) were 
prepared. Freshly prepared 50 µml of each test material (which is equal to 25 µml of 
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the drug) in gel state was placed in the well. Five wells for each test material i.e 
PVA + 2 % Chlorhexidine digluconate and   PVA + AgNPs + 2 % Chlorhexidine 
digluconate were allocated. Five wells for plain chlorhexidine and 5 wells for saline 
were allocated. 
Group No. 1:  2 % Chlorhexidine digluconate (5 wells) 
Group No. 2:  PVA + 2 % Chlorhexidine digluconate (5 wells) 
Group No. 3:  PVA + AgNPs + 2 % Chlorhexidine digluconate (5 wells) 
Group No. 4:  Saline (5 wells) 
The agar plates were then incubated at 37°C. The zone of inhibition was 
measured using a steel ruler from the outer most borders of the wells to the 
outermost border where the growth begins and multiplied by 2 and was recorded for 
each material at an interval of 1 hr, 1 day, 3 days and 7 days.  
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Antimicrobial studies 
Stock culture of E.Faecalis were grown on Sheep blood 
agar slope was suspended in 1 ml of peptone broth and 
incubated for 4 hours at 37° C 
The culture suspension was adjusted to match the 
turbidity equivalent of 0.5 MacFarland standard 
20 petridishes with sheep blood agar were 
streaked and incubated at 37 oC for 24 hours 
Wells of 5 mm deep and 10 mm in diameter were 
punched 
50 µml of the drug containing 25 µml of 2 % CHX 
solution was placed in the wells 
GROUP I  
2 % CHX 
(n=5) 
GROUP II  
PVA + 2 % CHX 
(n=5) 
 
GROUP III  
PVA + 2 % CHX + Ag NPs 
(n=5) 
 
GROUP IV  
Saline 
(n=5) 
 
Zone of inhibitions were measured 
after 1 hr, 24 hr, 72 hr and 168 hrs 
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RESULTS: 
 
UV Spectrophotometric studies: 
UV-Vis spectroscopy is routinely used in the quantitative 
determination of solutions or transition metal ions, highly conjugated 
organic compounds and biological macromolecules. In this study UV-Vis 
spectroscopy is used for the indication or the presence of chlorhexidine 
which produces characteristic peak in the UV visible region around 254 m 
and Silver nanoparticles which shows a peak at 412 nm. 
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Figure shows UV-Vis spectral changes during the formation of 
polymer-Ag NPs. A peak at 412 nm is due to the ligand-to-metal charge 
transfer which appears after heating the mixture of AgNO3 and PVA in 
water for one hour, indicating that silver ions are completely reduced in the 
solution. Chlorhexidine produce characteristic peak in the UV-Visible region 
around 254 nm. 
 The UV absorbance of a solution is directly proportional to the 
concentration of the absorbing species in the solution. The wavelengths of 
absorption peaks can be correlated with the types of bonds in a given 
molecule and are valuable in determining the functional groups within a 
molecule. 
In vitro drug release: 
The in vitro release of the drug from Group 2 and Group 3 was 
studied by the semipermeable membrane diffusion technique. The 
membrane allows the diffusion of the drug immediately into the receiver 
compartment containing the PBS solution. One mL samples of the solutions 
were withdrawn and replaced with an equal quantity of PBS solution. UV 
Spectrum of the samples was taken. The UV absorbance was converted into 
concentration to determine the released quantity of chlorhexidine. The 
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decimals were rounded to the nearest whole numbers. Results are tabulated 
in tables below. 
 
 
Time intervals Cumulative % of 
CHX release from 
Group 2 (PVA + 2 % 
CHX) 
Cumulative % of 
CHX release from 
Group 3 (PVA + 
AgNPs + 2 % CHX) 
1 hour 13 11 
24 hours 33 23 
48 hours 48 29 
72 hours 69 38 
96 hours 76 46 
120 hours 81 53 
144 hours 86 60 
168 hours 89 69 
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The following is the graphical representation of the comparison of the 
release kinetics of the two groups: 
 
I. The Results show that the release of CHX from Group 2 is initially high in 
the first 72 hours followed by a more sustained one, whereas the release 
from Group 3 is in a sustained manner throughout. 
II. The cumulative percentage of CHX release from Group 2 at the end of 1 
week is 89 % whereas that for Group 3 is 69 %. 
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Results of the microbiological studies: 
Group 1: 2 % CHX 
Group 2: PVA + 2 % CHX  
Group 3: PVA + AgNPS + 2 % CHX     
Group 4: Saline 
Zone of inhibition noted after 1 hour, 1 day, 3 days and 7 days. Each group 
has 5 reading in all these days. There was no zone of inhibition for Group 5 
(Saline). 
STATISTICAL ANALYSIS 
The statistical analysis was done by using Anova followed by Tukey, 
HSD test (SPSS 15 version) 
The following table shows the mean and standard deviation values of 
Group I, II and III at 1, 24, 72 and 168 hours 
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Zone of Inhibition in mm  
 
 
 
Hours 
Groups 
Group I Group II Group III 
Mean SD Mean SD Mean SD 
 1 9.20 1.30 2.40 1.14 .40 .55 
24 31.60 .55 12.00 1.58 16.60 2.07 
72 31.60 .55 25.80 1.30 24.80 1.30 
168 31.60 .55 28.80 1.10 29.00 .71 
 
 
Group 1: 2 % CHX 
 
Zone of inhibition measured in mm 
 1 hour 1 day 3 days 7 days 
Plate 1 8 32 32 32 
Plate 2 9 32 32 32 
Plate  3 10 31 31 31 
Plate 4 8 32 32 32 
Plate 5 11 31 31 31 
 
40 
 
GROUP I (Oneway) 
 
Zone of Inhibition in mm  
 
Hrs Mean Std. Deviation  
p Value 
1 9.20 1.304  
 
<0.001** 
24 31.60 .548 
72 31.60 .548 
168 31.60 .548 
Note: ** denotes significance at 1 % level 
 
 
Graphical representation of zone of inhibition of  Group I after 1 hr, 24 hr, 72 hr 
and 168 hrs. 
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Multiple Comparisons 
Dependent Variable: Zone of Inhibition in mm  
Tukey HSD 
 
(I) Hours (J) Hours 
Mean 
Difference 
(I-J) 
Std. Error p- Value 
95% Confidence Interval 
Lower Bound Upper Bound 
1 
24 -22.40(*) .510 .000 -23.86 -20.94 
72 -22.40(*) .510 .000 -23.86 -20.94 
168 -22.40(*) .510 .000 -23.86 -20.94 
24 1 22.40(*) .510 .000 20.94 23.86 
 
72 .00 .510 1.000 -1.46 1.46 
168 .00 .510 1.000 -1.46 1.46 
72 1 22.40(*) .510 .000 20.94 23.86 
 
24 .00 .510 1.000 -1.46 1.46 
168 .00 .510 1.000 -1.46 1.46 
168 1 22.40(*) .510 .000 20.94 23.86 
 
24 .00 .510 1.000 -1.46 1.46 
72 .00 .510 1.000 -1.46 1.46 
* The mean difference is significant at the .05 level. 
1. The difference between the values of the 1st hour compared with the 1st 
day, 3rd day and 7th day are highly significant with p value ≤ 0.001. 
2. But the difference between the values of 1st day, 3rd day and 7th day when 
compared with each other showed no difference and hence no 
significance. 
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Group 2: PVA + 2 % CHX 
Zone of inhibition measured in mm 
 1 hour 1 day 3 days 7 days 
Plate 1 3 12 24 28 
Plate 2 4 14 25 28 
Plate  3 2 10 27 30 
Plate 4 2 13 27 30 
Plate 5 1 11 26 28 
 
 
 
GROUP II (Oneway) 
 
Zone of Inhibition in mm  
 
 
 Mean Std. Deviation p value 
1 2.40 1.140  
 
 
<0.001** 
24 12.00 1.581 
72 25.80 1.304 
168 28.80 1.095 
Total 17.25 11.002 
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Multiple Comparisons 
Dependent Variable: Zone of Inhibition in mm  
Tukey HSD  
 
(I) Hours (J) Hours 
Mean 
Difference 
(I-J) 
Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
1 24 -9.60(*) .819 .000 -11.94 -7.26 
72 -23.40(*) .819 .000 -25.74 -21.06 
168 -26.40(*) .819 .000 -28.74 -24.06 
24 1 9.60(*) .819 .000 7.26 11.94 
 
72 -13.80(*) .819 .000 -16.14 -11.46 
168 -16.80(*) .819 .000 -19.14 -14.46 
72 
 
1 23.40(*) .819 .000 21.06 25.74 
24 13.80(*) .819 .000 11.46 16.14 
168 -3.00(*) .819 .010 -5.34 -.66 
168 1 26.40(*) .819 .000 24.06 28.74 
 
24 16.80(*) .819 .000 14.46 19.14 
72 3.00(*) .819 .010 .66 5.34 
* The mean difference is significant at the .05 level. 
1. The difference between the values of the 1st hour and 24 hour compared 
with 3rd day and 7th day are highly significant with p value ≤ 0.001. 
2. But the difference is less when the values of 72 hrs and 168 hrs is 
compared with p value = 0.010 and hence significant. 
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Graphical representation of the zone of inhibition for Group II after 1 hr, 24 hr, 
72 hr and 168 hr 
 
Group 3: PVA +AgNPs + 2 % CHX 
 
Zone of inhibition measured in mm 
 1 hour 1 day 3 days 7 days 
Plate 1 3 12 24 28 
Plate 2 4 14 25 28 
Plate  3 2 10 27 30 
Plate 4 2 13 27 30 
Plate 5 1 11 26 28 
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GROUP III (Oneway) 
 
Zone of Inhibition in mm  
 
 
 
 
Mean Std. Deviation P value 
1 .40 .548 
<0.001** 
24 16.60 2.074 
72 24.80 1.304 
168 29.00 .707 
Total 17.70 11.286 
 
 
 
Graphical representation of the zone of inhibition for Group III after 1 hr, 
24 hr, 72 hr and 168 hr 
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Multiple Comparisons 
Dependent Variable: Zone of Inhibition in mm  
Tukey HSD  
 
(I) Hours (J) Hours 
Mean 
Difference 
(I-J) 
Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
1 24 -16.20(*) .825 .000 -18.56 -13.84 
72 -24.40(*) .825 .000 -26.76 -22.04 
168 -28.60(*) .825 .000 -30.96 -26.24 
24 1 16.20(*) .825 .000 13.84 18.56 
 
72 -8.20(*) .825 .000 -10.56 -5.84 
168 -12.40(*) .825 .000 -14.76 -10.04 
72 1 24.40(*) .825 .000 22.04 26.76 
 
24 8.20(*) .825 .000 5.84 10.56 
168 -4.20(*) .825 .001 -6.56 -1.84 
168 1 28.60(*) .825 .000 26.24 30.96 
 
24 12.40(*) .825 .000 10.04 14.76 
72 4.20(*) .825 .001 1.84 6.56 
* The mean difference is significant at the .05 level. 
The differences between the values of all 4 intervals are highly significant 
with p value ≤ 0.001. 
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Intergroup Comparison 
Tables 
Zone of Inhibition in mm  
 
 
 
Group 
Group I Group II Group III 
Mean SD Mean SD Mean SD 
Hours 
1 9.20 1.30 2.40 1.14 .40 .55 
24 31.60 .55 12.00 1.58 16.60 2.07 
72 31.60 .55 25.80 1.30 24.80 1.30 
168 31.60 .55 28.80 1.10 29.00 .71 
 
 
 
Comparison in 1 hour (Oneway) 
 
Zone of Inhibition in mm  
 
 
 
Mean 
 
Std. Deviation 
 P value 
Group I 9.20 1.304 
<0.001** 
Group II 2.40 1.140 
Group III .40 .548 
Total 4.00 4.018 
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Multiple Comparisons 
Dependent Variable: Zone of Inhibition in mm  
Tukey HSD  
 
(I) 
Group 
(J) 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Group I Group II 6.80(*) .663 .000 5.03 8.57 
Group 
III 
8.80(*) .663 .000 7.03 10.57 
Group II Group I -6.80(*) .663 .000 -8.57 -5.03 
Group 
III 
2.00(*) .663 .027 .23 3.77 
Group 
III 
Group I -8.80(*) .663 .000 -10.57 -7.03 
Group II -2.00(*) .663 .027 -3.77 -.23 
* The mean difference is significant at the .05 level. 
1. The difference between the values of the Group I compared to Group II 
and group III after 1 hour are highly significant with p value ≤ 0.001. 
2. The difference between the values of Group II and group III is significant 
with the p value = 0.027. 
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Graphical representation of the comparison of zone of inhibition of all 3 Groups 
after 1 hr 
 
Comparison after 24 hours (Oneway) 
 
Zone of Inhibition in mm  
 
 Mean Std. Deviation 
 
P - Value 
Group I 31.60 .548 
<0.001** 
Group II 12.00 1.581 
Group III 16.60 2.074 
Total 20.07 8.779 
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Multiple Comparisons 
Dependent Variable: Zone of Inhibition in mm  
Tukey HSD  
 
(I) 
Group 
(J) 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Group I 
Group II 19.60(*) .973 .000 17.00 22.20 
Group 
III 15.00(*) .973 .000 12.40 17.60 
Group II Group I -19.60(*) .973 .000 -22.20 -17.00 
 Group III -4.60(*) .973 .001 -7.20 -2.00 
Group 
III Group I -15.00(*) .973 .000 -17.60 -12.40 
 Group II 4.60(*) .973 .001 2.00 7.20 
* The mean difference is significant at the .05 level. 
The difference between the values of Group I, II and III when compared to 
each other are highly significant. 
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Graphical representation of the comparison of zone of inhibition of all 3 Groups 
after 24 hr 
 
Comparison after 72 hours (Oneway) 
 
Zone of Inhibition in mm  
 
 
 
 
N 
 
Mean 
 
Std. Deviation 
 
 
p - Value 
Group I 5 31.60 .548 <0.001** 
Group II 5 25.80 1.304 
Group III 5 24.80 1.304 
Total 15 27.40 3.269 
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Multiple Comparisons 
Dependent Variable: Zone of Inhibition in mm  
Tukey HSD  
 
(I) 
Group 
(J) 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error 
Sig. 95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Group I Group II 5.80(*) .702 .000 3.93 7.67 
Group 
III 
6.80(*) .702 .000 4.93 8.67 
Group II Group I -5.80(*) .702 .000 -7.67 -3.93 
  Group 
III 
1.00 .702 .360 -.87 2.87 
Group 
III 
Group I -6.80(*) .702 .000 -8.67 -4.93 
Group II -1.00 .702 .360 -2.87 .87 
* The mean difference is significant at the .05 level. 
1. The difference between the values of the Group I when compared with 
group II and Group III are highly significant with p value ≤ 0.001. 
2. The difference between the values of Group II and Group III compared 
with each other showed no difference and hence no significance. 
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Graphical representation of the comparison of zone of inhibition of all 3 Groups 
after 72 hours 
 
Comparison after 168 hours (Oneway) 
 
Zone of Inhibition in mm  
 
 
 Mean Std. Deviation 
 
p - Value 
Group I 31.60 .548 
 
<0.001** 
Group II 28.80 1.095 
Group III 29.00 .707 
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Multiple Comparisons 
Dependent Variable: Zone of Inhibition in mm  
Tukey HSD  
 
 
(I) 
Group 
(J) 
Group 
Mean 
Difference 
(I-J) 
Std. 
Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Group I 
Group II 2.80(*) .516 .000 1.42 4.18 
Group 
III 2.60(*) .516 .001 1.22 3.98 
Group II Group I -2.80(*) .516 .000 -4.18 -1.42 
 Group III -.20 .516 .921 -1.58 1.18 
Group 
III Group I -2.60(*) .516 .001 -3.98 -1.22 
 Group II .20 .516 .921 -1.18 1.58 
* The mean difference is significant at the .05 level. 
1. The difference between the values of the Group I when compared with 
group II and Group III are highly significant with p value ≤ 0.001. 
2. The difference between the values of Group II and Group III compared 
with each other showed no difference and hence no significance. 
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Graphical representation of the comparison of zone of inhibition of all 3 Groups 
after 72 hours 
 
 
Comparison of Zones of inhibition for all the three groups at various time intervals  
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DISCUSSION 
 
Microorganisms play a fundamental role in the etiology of pulp and 
periapical diseases. Their control and elimination are important during 
endodontic treatment24. E. faecalis is probably the species that can best adapt 
to and tolerate the ecologically demanding conditions in the filled root 
canals. It is resistant to various antimicrobials. It is considered as a ‘star’ in 
post-treatment disease19. Because of this the development of effective 
therapeutic modalities against E. faecalis is desirable. Hence E. faecalis was 
chosen for the inoculum in this study. In addition, E. faecalis is relatively 
easy to culture and it has been used successfully in most studies with the 
original model2,16,29,33.   
Various modalities are attempted to eliminate residual bacteria from 
the root canal, which includes high end technologies as with LASERS, PAD 
(Photo Activated Disinfection) and ANILAD (Advanced Non invasive Light 
Activated Disinfection). Even though these show promising results, its 
applicability to all clinical settings and private practice may be difficult 
because of the exorbitant cost involved. A cost effective way to deal with the 
same situation is using intra canal medicaments. The use of an intra canal 
medicament helps in the elimination of bacteria that remains even after 
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cleaning and shaping, thereby providing an environment conducive for 
periapical tissue repair6. 
Many medicaments were used as intracanal dressings in the past 
decades and according to their chemical basis, generally fall into the 
following categories: phenolic derivatives (eugenol, camphorated 
paramonochlorophenol, camphorated phenol, metacresyl acetate, beechwood 
creosote), aldehydes (formocresol), halides (iodine–potassium iodide), 
calcium hydroxide, antibiotics, and various combinations.  
The most popular intracanal medicament in use currently is calcium 
hydroxide. However, various studies confirmed the resistance of E. faecalis 
to Calcium hydroxide. Various newer medicaments are also tried nowadays, 
as Bioactive glass and Octanidine. 2% Chlorhexidine (CHX) has been found 
to be highly active against E. faecalis8. CHX seems to act by adsorbing on to 
the cell wall of microorganisms and causing the leakage of intracellular 
components. In addition, it is retained by the dentinal hard tissues and thus 
has a substantive antimicrobial action2,16,29. The cationic properties of 
chlorhexidine allow it to be absorbed on to hydroxyapatite32. It was also 
suggested as an effective irrigant to prevent root canal re-infection due to 
coronal leakage22. However, to achieve long-term substantive anti microbial 
effect, the infected root dentin must be exposed to CHX for a longer time 
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than that afforded by irrigation16,32. It therefore seems reasonable to assume 
that chlorhexidine has a potential role as an effective intracanal medicament.   
CHX is an effective intracanal irrigation compared with 5% Sodium 
hypochlorite22.  However, the relatively short exposure time (a few minutes 
at the most) in the root canal during irrigation does not allow the medication 
to apply its full antibacterial properties. Thus, a large amount of bacteria 
remained in the dentinal tubules. The limited antibacterial effect of CHX 
irrgation is due to the fact that during the first hour of irrigation the dentin 
absorbs the medication61 and it is only after the saturation point after the first 
hour that the antibacterial capability of CHX increases with time. Therefore 
the sustained release mechanisms provide an optimal condition for a 
maximal antibacterial effect of the medication73. 
A major research thrust in the pharmaceutical and chemical industry is 
the development of controlled release systems for drugs and bioactive agents.  
Many of these delivery systems in use and under development consist of a 
drug dispersed within a polymeric carrier.  These carriers are designed to 
release the drugs in a controlled fashion for times ranging from minutes to 
years. 
Thus, polymers have gained in importance in the pharmaceutical 
industry as both drug encapsulants and vehicles of drug carriage. They have 
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the property of sustained/retarded release, and/or selective delivery of the 
drug to the targeted organs. Advantages of sustained release systems thus 
include: delivery to the required site; delivery at the required rate; fewer 
applications; and also economic advantages by virtue of more efficient 
dosage.  
Sustained release of chlorhexidine has been studied from various 
polymeric media like gelatin4, collagen1, ethyl cellulose10, resins7,23, fibres51, 
Glass ionomer Cement40, chitosan37,56, PMMA Polymethyl methacrylate33 
and PLGA poly(lactic-co-glycolic acid)51. Most of these sustained release 
systems have found profound application in periodontology wherein they are 
used inside the infected periodontal pockets. 
There are considerable studies in the field of endodontics regarding 
the sustained release of Chlorhexidine. . The ideal controlled release drug 
device for endodontic usage should have the following characteristics. It 
should not degrade inside the root canal and it should be easily inserted into 
and removed from the root canal. In addition, the drug should be released 
continuously for a controlled time period. 
 Friedman & Steinberg (1989) first introduced a degradable sustain 
release device (SRD) to dentistry which contained chlorhexidine gluconate 
as the active agent. It was later evaluated for endodontic use by Heling et al 
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in 1990.  The matrix of this SRD is composed of a crosslinked protein with 
chlorhexidine gluconate embedded as the active agent.The rate of release of 
chlorhexidine gluconate from the device depends on the following factors16: 
I. The initial amount of chlorhexidine loaded into the film. 
II. There is an inverse relationship between the crosslink density and the 
rate of Chlorhexidine release from the film. The higher the crosslink 
density, the more prolonged the antibacterial activity. 
III. The amount of liquid in the root canal that will be absorbed by the 
device. 
IV. The number of bacteria which enhance the biological enzymatic 
degradation mechanism. 
In a study conducted by Spa°ngberg and Doug-Youn Lee in 200537, a 
needle shaped controlled release prototypes, first developed by Huang et al17 
were used. The prototypes (paper points) were either coated (with polymers) 
or non-coated and loaded with chlorhexidine and its release was studied. 
They demonstrated that the releasing rate of the prototype with non-coated 
formulation was very fast (CHX was released within 2 hours). In contrast, 
the release rate of the prototypes with coated formulations was far more 
controlled. The polymer coatings used were chitosan, PLGA and PMMA. 
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Chitosan was more sensitive to water and easily swollen with water 
and ruptured. This resulted in faster release of CHX from the chitosan-
coated prototype compared to the PLGA- and PMMA-coated groups. The 
CHX loaded in the paper point was released through the surface pores on the 
coated polymer layer. The pore size of PLGA-coated group was larger than 
that of PMMA-coated group and the release rate of CHX from the latter 
group was lower than that of the former group. Thus, drug release can be 
controlled by controlling the pore size of the coated polymer. 
Shaul Lin et al61 used Activ Point containing CHX as intracanal 
medicament. The advantages which he quoted were: Gutta-percha points 
containing CHX are IS0 sizes and radiopaque, the compatible IS0 size Activ 
Point is accurately applied to the working length after irrgation with saline 
solution. It is not necessary to dry the canals because the gutta-percha points 
release the CHX in the presence of the solution. The accurate application of 
the gutta-percha points to the working length ensures antibacterial activity 
along the root canal and prevents extension of the medication into the 
periradicular tissues. Removal of the gutta-percha points after 7 or 14 days is 
easy and eliminates the possibility of paste remnants on the dentinal walls, 
which could disturb the adhesive properties of the intracanal sealer. They 
concluded that Activ Point seems to be an effective intracanal medication 
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with high penetration ability to dentinal tubules and strong antibacterial 
properties. 
In a more recent study by Yoon Lee et al 200873 evaluation of a 
similar PCRD (Polymeric chlorhexidine control release device) coated with 
Polymethyl methacrylate and loaded with high concentration of CHX as an 
intracanal medicament was done and proved it to be superior than Calcium 
hydroxide and 0.2% chlorhexidine. 
The above mentioned studies have been carried out for the in vitro 
application of the sustained release mechanism of Chlorhexdine which have 
already been proved.  In this study a well known polymer in the field of 
polymer science and pharmaceutical industry known as Polyvinyl alcohol 
(PVA) has been used to evaluate the control release of the drug of our choice 
which is chlorhexidine digluconate. PVA has been chosen in this study 
because it is a hydrophilic polymer with unique properties of absorbing 
water and forming hydrogels and therefore is extensively used in sustained 
release applications20. 
PVA possesses a variety of advantageous chemical and physical 
properties like chemical resistance, high melting point and biological 
compatibility and represents an inexpensive, non-toxic material which is 
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commercially available in a broad range of degrees of polymerisation and 
hydrolysis59. 
The chemical structure of Polyvinyl alcohol is as follows with a glass 
transition temperature of 85 0C. 
 
Polyvinyl alcohol Tg = 850C 
We have employed the hydrogel forming property of PVA in our 
study for the sustained release of Chlorhexidine.  One major class of 
polymers that has been identified for use in controlled release applications is 
hydrogels. Hydrogels are three-dimensional, water-swollen structures 
composed of mainly hydrophilic homopolymers or copolymers44. The 
crosslinked three dimensional polymeric arrays can imbibe large quantities 
of water. In the hydrated state these materials are moist, pliable and can 
conform to irregular surfaces11. These materials are for the most part 
insoluble due to the presence of chemical or physical crosslinks. The 
physical crosslinks can be entanglements, crystallites or weak associations 
such as van der Waals forces or hydrogen bonds.  The crosslinks provide the 
network structure and physical integrity.      
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Hydrogels are classified in a number of ways.  They can be neutral or 
ionic based on the nature of the side groups.  They can also be classified 
based on the network morphology as amorphous, semicrystalline, hydrogen-
bonded structures, supermolecular structures and hydrocolloidal aggregates.  
Additionally, in terms of their network structures, hydrogels can be 
classified as macroporous, microporous, or nonporous. 
Because of their wide range of properties, hydrogels have been 
considered in drug delivery applications for over 30 years. Some of the 
application of hydrogels include55;  
 Wound healing wherein antibacterial drugs like chlorhexidine and 
coagulants can be formulated with gelatin and PVA hydrogel,  
 Controlled delivery of ibuprofen to colon has been achieved 
through hydrogel of guargum cross linked with glutaraldehyde,  
 In topical delivey like desonide, cotrimazole, in ocular delivery of 
pilocarpine, timolol, diclofenac, pheneramine maleate.  
 Two of the most important characteristics in evaluating the ability of a 
polymeric gel to function in a particular controlled release application are 
the network permeability and the swelling behavior. The permeability and 
swelling behavior of hydrogels are strongly dependent on the chemical 
nature of the polymer(s) composing the gel as well as the structure and 
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morphology of the network.  As a result, there are different mechanisms that 
control the release of drugs from hydrogel-based delivery devices and these 
characteristics allow these systems to provide many different release profiles 
to match desirable release profiles.   
A schematic representation of a hydrogel structure is given below 
(Anthony M.Lowman) 
 
Schematic representation of the cross-linked structure of a hydrogels.  cM  is the 
molecular weight of the polymer chains between crosslinks and  is the network 
mesh size. 
 
 The transport or release of a drug through a polymeric controlled 
release device can be described by classical Fickian diffusion theory.  This 
theory assumes that the governing factor for drug transport in the gels is 
ordinary diffusion. 
Mc, 
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 The structure and morphology of a polymer network will significantly 
affect the ability of a drug to diffuse through a hydrogel.  For all types of 
release systems, the diffusion coefficient of solutes in the polymer is 
dependent on a number of factors such as the structure and pore size of the 
network, the polymer composition, the water content and the nature and size 
of the solute. Macroporous hydrogels have large pores, usually between 0.1 
and 1 m.  Microporous Hydrogels have pore sizes between 100 and 1000 Å.  
 Polyvinyl alcohol hydrogels have been used for controlled drug 
delivery system for many drugs like propanalol, atenalol, indomethacin, 
phenylpropanalamine36, theophylline20 etc. There have been very few studies 
in the past which have dealt with PVA hydrogel for the controlled release of 
Chlorhexidine.  
The hydrogels formed by PVA is quite hydrophilic system, it releases 
drug with relatively high rates. Therefore, to prolong the drug release from 
such system, its molecular structure should be modified. Usually this is done 
by cross linking and reducing the macromolecular mesh size available for 
drug diffusion20. The crosslinking can be chemical or physical. Chemical 
crosslinking includes addition of cross linkers like Gluteraldehyde, glycerol 
etc under acidic condtions20.  
67 
 
In our study we have carried out the physical cross linking by heating 
the polymer above its glass transition temperature Tg (85°C). In such 
conditions the polymer chains gain enough mobility to align themselves and 
therewith to migrate into more ordered and energetically favourable 
conformations59. Also strong hydrogen bonding between neighbouring 
polymer chains holds the molecules in a regular structure and forms ordered 
regions (crystallites) beside the amorphous polymer matrix58.   
Gay et al11 has used PVA for the slow release of chlorhexidine 
diphosphanilate for wound dressings and had studied the results for a period 
of 1week. He had taken PVA of different grades (523, 425, 350) depending 
on the degree of hydrolysis and other parameters and had shown that the 
release was complete for PVA 523 in 40 hrs whereas only 50 % of the drug 
was released from PVA 425 and 350 after 40 hrs and the release continued 
after that. He concluded that greater is the degree of hydrolysis, more is the 
solubility in water and rate of release is faster. PVA 523 has a degree of 
hydrolysis of 87-89 % whereas for PVA 425 it is 95.6 – 96.5 % and for PVA 
350 it is 98-98.8%.  In this study PVA with a degree of hydrolysis of 97.5-
99.5 % hydrolysis has been used. 
Importantly, two groups have been compared in this study one is 
Group 2 wherein release of CHX from Polyvinl alcohol and the other is 
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Group 3 wherein effect of Silver nanoparticles (AgNPs) on the release of 
CHX from Polyvinyl alcohol and the antibacterial activity are seen. The 
results of the release study showed that nearly 89 % of the drug was released 
in a period of a week from plain PVA (Group 2) whereas only 69 % of the 
drug was released from PVA with AgNPs (Group 3). The release continued 
for the two groups thereafter. For group 2 the release was high in the first 72 
hrs followed by a more sustained one.  
The reason for the initial burst may be due to non uniform or 
heterogenous drug distribution74 and the surface bound drug particles which 
are first released followed by the release of more deeply entrapped ones in 
the meshwork. The minimal disadvantage of burst release is that it leads to a 
loss in treatment efficacy, as drug is lost in an uncontrolled and 
unpredictable pattern72. For group 3 the initial burst was not very significant 
and the release was approximately uniform. The slower drug release from 
this group may be attributed to the presence of silver nanoparticles which 
alter the drug release from a polymer depending on the size. The 
nanoparticle size was associated with change in drug release kinetics. The 
smaller size nanoparticles prepared with lower amount of polymer exhibited 
higher drug release rate, this is may be due to the increased nanoparticle 
surface resulting in larger drug fraction exposed to the dissolution medium 
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and also the higher amount of drug loading. The larger size nanoparticles 
prepared with higher amount of Polymer exhibited lower drug release rates, 
this may be due to the decreased nanoparticle surface resulting in smaller 
drug fraction exposed to the dissolution medium and also the lower amount 
of drug loading38.  Therefore, further studies are required wherein the 
nanoparticle size should be standardized for better control of sustained drug 
release. 
The agar diffusion test was employed in this study to determine the 
antimicrobial efficacy of the test medicaments. The agar diffusion test is 
generally an accepted method to test the antimicrobial activity of endodontic 
medicaments and irrigating solutions. This test is a standardized one making 
it reproducible and simple to perform and relatively inexpensive. 
 The results of the agar diffusion test which was done at intervals of 1 
hr, 1 day 3 days and 7 days showed that compared to Group 1 (2% CHX), 
Group 2 and 3 showed slower release of the drug and hence slowly 
developing zone of inhibition. Within 1 hour Group 1 attained its maximum 
zone of inhibition and there was no change in it after 7 days also. For Group 
2 the release after 1 hour was not very significant but it increased and the 
zone of inhibition after 3 days was significantly larger. Thereafter the 
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increase was at a lower rate. At the end of seven days when compared to 
Group 1, the zone of inhibition of Group 2 was smaller by an average of 3 mm.  
 In Group 3, the zone of inhibition was negligible in the 1st hour, it slowly 
increased in size and after 1 day it attained size greater than group 2. The zone of 
inhibition further increased and the average of the readings at the end of both 3rd and 
7th day was mildly larger that group 2. This is not in accordance with the release 
studies because, in the microbiological studies, the effect of the silver nanoparticles is 
synergistic with Chlorhexidne against E. Faecalis. The antibacterial activity of silver 
nanoparticles against E. Faecalis has been proved70. 
Some factors such as the pH of the substrate, incubation period, toxicity, and 
sensitivity and diffusion capacity of the drug may have an impact on the antimicrobial 
activity of the test materials in the plates. Also, this is the first time that a combination 
of PVA, AgNPs and chlorhexidine has been used in the agar diffusion test. The 
components may have effect on the diffusion of chlorhexidine. 
This is a very preliminary study to prove a point that chlorhexidine can be 
slowly released from biocompatible hydrogels like PVA. Further studies are required 
to find out the methods of better manipulation, further improvement of the polymers 
for better sustainment of the drug, modifications in the concentration of the drug 
used for better efficacy and the results of application of  this sustained 
release system and their efficacy in the more complicated in vivo conditions.  
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SUMMARY 
 
Endodontic treatment is targeted towards the reduction and 
elimination of microorganisms from the root canal system. Intra canal 
medicaments can aid in achieving this objective. 2 % CHX is being used as a 
successful irrigant against many pathogens in endodontics. The drawback 
with the irrigant is that the solution is in contact with the root canal dentin 
for a very short period of time. Hence, the use of this drug as an intra canal 
medicament with a sustained drug releasing medium would be more 
efficient in the elimination of the pathogens. 
This study analyses the release mechanism of 2 % CHX from a 
polymeric medium for a prolonged period of time (1 week) so that it can be 
used as an intra canal medicament to get enhanced results. A well known 
polymer used in the pharmaceutical industry as a drug carrier called 
polyvinyl alcohol with the property of forming hydrogel is used here. 2 % 
CHX is incorporated in this hydrogel matrix (Group 2) and the slow release 
of this drug is studied over a period of a week.  
In Group 3 the above mentioned combination along with the effect of 
silver nanoparticles is studied and the results are compared with that of the 
72 
 
plain chlorhexidine (Group 1). Group 2 with PVA and 2 % CHX showed 89 
% of the drug release at the 168th hour (7th day). Group 3 with PVA and 
AgNPs and 2 % CHX showed 69 % of the drug release at the end of 168th 
hour. 
  Agar diffusion method was used to compare the zone of inhibition 
produced by the slow release of the drug against E faecalis over a period of a 
week. The following groups were tested.  
Group 1: 2 % CHX 
Group 2: PVA + 2 % CHX  
Group 3: PVA + AgNPS + 2 % CHX     
Group 4: Saline 
 The results were monitored on 1st hour, 1st day, 3rd day and 7th day. 
Group 1 showed maximum zone of inhibition within 24 hours, whereas the 
zone of inhibition slowly increased over a period of a week for the 2nd and 
the 3rd group showing the slow drug release. Group 4 with saline showed no 
zone of inhibition. 
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CONCLUSION 
 
Chlorhexidine is widely used in the field of endodontics as it is highly 
effective against many root canal pathogens including E faecalis. The result 
of the present study shows that the efficacy of chlorhexidine can be further 
enhanced by incorporating the drug in a sustained release medium as it 
makes the availability of the drug throughout the course of the treatment. 
The usage of polyvinyl alcohol as a carrier of the drug along with the 
synergistic properties of silver nanoparticles, opens a new avenue of trying a 
biocompatible polymer in endodontics as an intra canal medicament to act 
against the microorganisms in the root canal system for an extended period 
of time and aid in the success of endodontic treatment. 
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